ArticleArXiv2025
Improving Biomedical Knowledge Graph Quality: A Community Approach.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Biomedical knowledge graphs (KGs) are widely used across research and translational settings, yet their design decisions and implementation are often opaque. Unlike ontologies that more frequently adhere to established creation principles, biomedical KGs lack consistent practices for construction, documentation, and dissemination. To address this gap, we introduce a set of evaluation criteria grounded in widely accepted data standards and principles from related fields. We apply these criteria to 16 biomedical KGs, revealing that even those that appear to align with best practices often obscure essential information required for external reuse. Moreover, biomedical KGs, despite pursuing similar goals and ingesting the same sources in some cases, display substantial variation in models, source integration, and terminology for node types. Reaping the potential benefits of knowledge graphs for biomedical research while reducing duplicated effort requires community-wide adoption of shared criteria and maturation of standards such as Biolink and KGX. Such improvements in transparency and standardization are essential for creating long-term reusability, improving comparability across resources, providing a rigorous foundation for artificial intelligence models, and enhancing the overall utility of KGs within biomedicine.
Identifiers
40909156PMC12407614What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.